In contrast with other potential immunomodulatory factors in PDAC like CXCL12 (66) or Galectin 1 (67), which have been shown to be produced by stromal cells, gal 4 is produced by tumor cells and secreted to the ECM. This evidence concerns the gene CXCL12 and neoplasm.